SPEED TRIO FELVFIVCORONA

Informazioni principali

  • Nome commerciale:
  • SPEED TRIO FELV/FIV/CORONA
  • Confezione:
  • Scatola da 6 test
  • Tipo di ricetta:
  • Libera vendita
  • Utilizzare per:
  • Animali
  • Tipo di medicina:
  • Dispositivo medico

Documenti

  • per i professionisti:
  • Il foglio illustrativo per questo prodotto non è al momento disponibile, é possibile inviare una richiesta al nostro Servizio Clienti ed essere avvisati nel momento in cui è disponibile sulla nostra piattaforma.


    Richiedi il foglio illustrativo per i professionisti.

Localizzazione

  • Disponibile in:
  • SPEED TRIO FELV/FIV/CORONA
    Italia
  • Lingua:
  • italiano

Informazioni terapeutiche

  • Gruppo terapeutico:
  • Gatti
  • Area terapeutica:
  • Tutti gli altri prodotti non terapeutici
  • Indicazioni terapeutiche:
  • Diagnosi rapida FeLV/FIV/CORONA su plasma, siero o sangue intero (con anticoagulante).
  • Dettagli prodotto:
  • Posologia: Con una pipetta mantenuta in posizione verticale, deporre una goccia del campione in ogni pozzetto. Deporre 5 gocce di REAGENTE in ogni pozzetto. Tempo di lettura: 15 minuti di migrazione.

Altre informazioni

Status

  • Fonte:
  • Ministero della Salute - Italia
  • Numero dell'autorizzazione:
  • 935776132
  • Ultimo aggiornamento:
  • 14-08-2017

Foglio illustrativo: composizione, posologia, indicazioni, interazioni, gravidanza, allattamento, effetti indesiderati, controindicazioni

Speed Trio FeLV/FIV/Corona

Q INTERESSE CLINICO

3L PUMLaPVUP JH\ZH[L KHS =PY\Z KLSSH 3L\JLTPH MLSPUH -L3= KHS

=PY\ZKLSS»PTT\UVKLÄJPLUaH-LSPUH-0=LKHS*VYVUH=PY\Z-LSPUV

-*V=ZVUVJVUZPKLYH[LSHTHNNPVYLJH\ZH\UP]LYZHSLKPTVY[HSP[n

[YH SL WH[VSVNPL PUML[[P]L ULS NH[[V 8\LZ[P ]PY\Z ]LUNVUV [YHZTLZZP

WYPUJPWHSTLU[L

H[[YH]LYZV

JVU[H[[P

YH]]PJPUH[P

[YH

NH[[P

ZHSP]H

ZLJYLaPVUPUHZHSPMLJP

3L PUMLaPVUP KV]\[L HS ]PY\Z -L3= L HS -0= L HS *VYVUH]PY\Z MLSPUV

WYLZLU[HUV MVY[P ZVTPNSPHUaL JSPUPJOL PS JOL YLUKL TVS[V KPMÄJPSL

\UHSVYVKPHNUVZPKPMMLYLUaPHSL!

PZPU[VTPZVUVTVS[V]HYPHIPSPLZWLZZVWVJVL]PKLU[P

SLK\LTHSH[[PLZVUVHJJVT\UH[LKHZ]HYPH[PZPU[VTP!HIIH[[PTLU[V

HUVYLZZPHPWLY[LYTPHZPUKYVTLKHPTT\UVKLÄJPLUaHHULTPH

Q PRINCIPIO

:WLLK;YPV-L3=-0=*VYVUHu\U[LZ[X\HSP[H[P]VYHWPKVIHZH[VZ\S

WYPUJPWPVKLSS»PTT\UVJYVTH[VNYHÄHZ\TLTIYHUHJOLWLYTL[[LKP

TL[[LYLPUL]PKLUaHSHWYLZLUaHKPHU[PNLUPKLS-L3=LKPHU[PJVYWP

HU[P-0=LKPHU[PJVYWPHU[P*VYVUH]PY\ZULSNH[[V

7LYVNUP[LZ[uZ\MÄJPLU[LKLWVYYL\UHNVJJPHKPJHTWPVULZPLYV

WSHZTH V ZHUN\L PU[LYV JVU HU[PJVHN\SHU[L ULS WVaaL[[V KLP

JHTWPVUP <UH ]VS[H KLWVZ[V PS JHTWPVUL SL WHY[PJLSSL JVSVYH[L

KLS JVUP\NH[V ZP SLNHUV HNSP HU[PNLUP 7 KLS -L3= WHY[L -L3=

HNSP HU[PJVYWP HU[P-0= KLS NH[[V WHY[L -0= L HNSP HU[PJVYWP HU[P

-*V= KLS NH[[V WHY[L -*V= 0 JVTWSLZZP JVUP\NH[VHU[PNLUP KLS

-L3=LJVUP\NH[VHU[PJVYWPKLS-0=LJVUP\NH[VHU[PJVYWPKLS-*V=

JVZy MVYTH[P TPNYHUV WLY JHWPSSHYP[n Z\SSH TLTIYHUH =LUNVUV

X\PUKP JH[[\YH[P KH HU[PJVTWSLZZP ZWLJPÄJP ÄZZH[P Z\SSH TLTIYHUH

L MVYTHUV WLY HJJ\T\SV KP WHY[PJLSSL JVSVYH[L \UH IHUKH [LZ[

Speed Trio FeLV/FIV/Corona

Kit di diagnosi veterinaria

Solo per uso in vitro

IT-1

KP JVSVYL YVZH WHY[L JLU[YHSL KLSSH ÄULZ[YH 3»PUZPLTL TPNYH Z\S

Z\WWVY[V ÄUV H YHNNP\UNLYL S»LZ[YLTP[n KLSSH TLTIYHUH KV]L SL

WHY[PJLSSLJVSVYH[LYPTHULU[PMVYTHUV\UHIHUKHKPJVU[YVSSVYVZH

JOLJVUMLYTHSHJVYYL[[HLZLJ\aPVULKLS[LZ[

Q PROTOCOLLO OPERATIVO

PER OGNI TEST PREVEDERE:

<UHJLSSH[LZ[\UHWPWL[[HTVUV\ZVPSÅHJVULKPYLHNLU[L

<[PSPaaHYLPYLHNLU[PH[LTWLYH[\YHHTIPLU[L

Non mescolare mai reagenti di lotti diversi.

1/ DEPOSITO DEL CAMPIONE:

:PLYVWSHZTHZHUN\LPU[LYVJVUHU[PJVHN\SHU[L,+;(VLWHYPUH!

pipetta

TVUV\ZV

THU[LU\[H

WVZPaPVUL

]LY[PJHSL

deporre 1 gocciaKPJHTWPVULULSWVaaL[[VKLPJHTWPVUP

2/ DEPOSITO DEL REAGENTE:

 (NNP\UNLYL PS YLHNLU[L Z\IP[V KVWV H]LY KLWVZ[V PS JHTWPVUL

4HU[LULYL

ÅHJVUL

YLHNLU[L

WVZPaPVUL

]LY[PJHSL

aggiungerne 5 goccePUVNUPWVaaL[[VKLSJHTWPVUL

 :LSLTPNYHaPVULUVUPUPaPHLU[YVTPU\[Paggiungere altre 2

gocceKPYLHNLU[LULSWVaaL[[VKLSJHTWPVUL

3/ LETTURA E INTERPRETAZIONE DEI RISULTATI :

3LNNLYLPSYPZ\S[H[VKVWVTPU\[PKPTPNYHaPVUL!

- Se il TEST È NEGATIVOJVTWHYL1 banda rosa nella

WHY[LKLZ[YHKLSSHÄULZ[YHKPSL[[\YHZ[YPZJPHKPJVU[YVSSV

- Se il TEST È POSITIVOJVTWHPVUV2 bande rosaILU

KPZ[PU[L ULSSH ÄULZ[YH KP SL[[\YH IHUKH [LZ[  IHUKH KP

JVU[YVSSV

3HJVTWHYZHKP\UHIHUKH[LZ[KVWVZVSVTPU\[PKP

TPNYHaPVULWLYTL[[LKPJVUJS\KLYLJOLPS[LZ[uWVZP[P]V

<UH JVSVYHaPVUL HUJOL TVS[V SPL]L KLSSH Z[YPZJPH [LZ[

KL]LLZZLYLJVUZPKLYH[HJVTL\UYPZ\S[H[VWVZP[P]V

IT-2

-3»HZZLUaHKLSSHIHUKHKPJVU[YVSSVZPNUPÄJHJOLPS[LZ[

non è valido.

INTERPRETAZIONE DEL TEST FCoV:

<UYPZ\S[H[V-JV=WVZP[P]VPUKPJHJOLuH]]LU\[V\UJVU[H[[VJVU

PSJVYVUH]PY\Z0NH[[PZPLYVWVZP[P]PWVZZVUVWYLZLU[HYLPS]PY\ZULSSL

MLJP

5LSNH[[VTHSH[VS»L]PKLUaPHaPVULKLNSPHU[PJVYWPHU[PJVYVUH]PY\Z

WLYTL[[L PUZPLTL HK HS[YP LZHTP JVTWSLTLU[HYP KP ]HS\[HYL SH

WYVIHIPSP[nJOLS»HUPTHSLZPHHMML[[VKHWLYP[VUP[LPUML[[P]HMLSPUH0U

JHZVKPTHSH[[PHM\STPUHU[LWLY~VHS[LYTPULKLSS»L]VS\aPVULKLSSH

THSH[[PHZ[LZZHSHJYLHaPVULKPPTT\UVJVTWSLZZPW\~KL[LYTPUHYL

\UHJHK\[HKLS[HZZVKPHU[PJVYWPLMVYUPYL\UYPZ\S[H[VMHSZVULNH[P]V

Q RACCOMANDAZIONI

‹:;()030;±*65:,9=(A065,!

 

TLZP

[LTWLYH[\YH

HTIPLU[L

WHY[PYL

KHSSH

KH[H

MHIIYPJHaPVUL3HKH[HKPZJHKLUaHuYPWVY[H[HZ\SRP[LZ\VNUPI\Z[H

JVU[LULU[LP[LZ[

- *VUZLY]HYL H [LTWLYH[\YH HTIPLU[L [YH   ‡* L  ‡* 5VU

LZWVYYLPS[LZ[H[LTWLYH[\YL[YVWWVLSL]H[LVPUMLYPVYPH‡*

‹ CAMPIONI:

 0 JHTWPVUP KP ZPLYV WSHZTH V ZHUN\L PU[LYV JVU HU[PJVHN\SHU[L

KL]VUVLZZLYLH[LTWLYH[\YHHTIPLU[LHSTVTLU[VKLSS»\[PSPaaV

 0SSPX\PKVHZJP[PJVVPUNLULYHSLP]LYZHTLU[PUVUZVUVJVU]HSPKH[P

JVTLJHTWPVUPWLY[LZ[-L3=L-0=WLY[HU[VUVUKV]YLIILYVLZZLYL

\[PSPaaH[PWLYX\LZ[P

 *VUZLY]HaPVUL KLP JHTWPVUP ÄUV H  VYL! JVUZLY]HYL ZPLYV

WSHZTHVZHUN\LPU[LYVJVUHU[PJVHN\SHU[LH[LTWLYH[\YHHTIPLU[L

  *VUZLY]HaPVUL KLP JHTWPVUP ÄUV H  VYL! JVUZLY]HYL ZPLYV

V WSHZTH [YH  ‡* L  ‡* PU MYPNVYPMLYV 3H JVUZLY]HaPVUL KLS

ZHUN\L PU[LYV WLY KP]LYZL VYL [YH   ‡* L  ‡* W\~ WYV]VJHYL

\U»LTVSPZPWHYaPHSLUVU]PZPIPSLHVJJOPVU\KVJOLW\~YLUKLYLWPƒ

IT-3

KPMÄJPSLS»PU[LYWYL[HaPVULKLS[LZ[

  6S[YL SL  VYL JVUZLY]HYL ZPLYV L WSHZTH H  ‡* 5VU

JVUNLSHYLTHP\UJHTWPVULKPZHUN\LPU[LYV

‹ PRECAUZIONI PER LA MANIPOLAZIONE:

  7LY V[[LULYL \UH TPNYHaPVUL JVYYL[[H KLS JHTWPVUL TL[[LYL SH

JLSSH[LZ[Z\\UHZ\WLYÄJPLWPHUHLVYPaaVU[HSL

 7LYZ[HUKHYKPaaHYLSHX\HU[P[nKPJHTWPVULULJLZZHYPHWLYJPHZJ\U

[LZ[\[PSPaaHYLLZJS\ZP]HTLU[LSLWPWL[[LWYLZLU[PULSSHJVUMLaPVUL

 7LYKLWVYYLJVYYL[[HTLU[LPSJHTWPVULLPSYLHNLU[LTHU[LULYLPS

ÅHJVULJVU[HNVJJLKLSYLHNLU[LLSHWPWL[[HPUWVZPaPVUL]LY[PJHSL

‹

ALTRE RACCOMANDAZIONI :

 +\YHU[LS»LZLJ\aPVULKLS[LZ[SHÄULZ[YHKPSL[[\YHW\~TVZ[YHYL

\UHSPL]LJVSVYHaPVULYVZHJOLUVUOHHSJ\UHJVUZLN\LUaHZ\SSH

X\HSP[nKLSYPZ\S[H[V

- Non mescolare reagenti di lotti diversi.

  3HZJPHYL JOL P YLHNLU[P YHNNP\UNHUV SH [LTWLYH[\YH HTIPLU[L

WYPTHKLSS»\ZV

 <[PSPaaHYL\UHU\V]HWPWL[[HTVUV\ZVWLYVNUP[LZ[

8\LZ[L YHJJVTHUKHaPVUP JVZ[P[\PZJVUV ZVSV \UH N\PKH PU X\HU[V

UVU ZP W\~ WYL[LUKLYL JOL HSJ\U TL[VKV KPHNUVZ[PJV ZPH WYLJPZV

HS 3VZJVWVKPX\LZ[V[LZ[uHP\[HYLPS]L[LYPUHYPVHYP]LSHYL

SHWYLZLUaHKPHU[PNLUPKLS-L3=LKPHU[PJVYWPHU[P-0=LHU[P-JV]

ULS NH[[V 3»PU[LYWYL[HaPVUL KLS [LZ[ KH WHY[L KLS ]L[LYPUHYPV KV]Yn

ZLTWYL[LULYLJVU[VKLSS»HUHTULZPKLSS»LZHTLJSPUPJVKLSS»HUPTHSL

LKLSYPZ\S[H[VKPL]LU[\HSPHS[YPLZHTPJVTWSLTLU[HYP3HKPHNUVZP

ÄUHSLYLZ[H\UHWYLYVNH[P]HKLS]L[LYPUHYPVJ\YHU[LLKuZV[[VSHZ\H

YLZWVUZHIPSP[n

)PV

=L[V

;LZ[

UVU

W\~

LZZLYL

YP[LU\[H

YLZWVUZHIPSL

KLSSL

JVUZLN\LUaL SLNH[L H \U \[PSPaaV ZJVYYL[[V V H \U»PU[LYWYL[HaPVUL

ZJVYYL[[HKLPYPZ\S[H[PMVYUP[PKHX\LZ[V[LZ[

IT-4

17-1-2019

SRAM recalls three-speed internal gear hub with coaster brake

SRAM recalls three-speed internal gear hub with coaster brake

The brake can fail, posing a crash or fall hazard to the rider.

Health Canada

10-1-2019

Stanley Black & Decker Canada Corp. recalls DEWALT DWD110 and DWD112 variable speed reversing drills

Stanley Black & Decker Canada Corp. recalls DEWALT DWD110 and DWD112 variable speed reversing drills

The internal wiring of the DEWALT 3/8-inch variable speed reversing drills can come into contact with internal parts, posing a risk of electrical shock.

Health Canada

20-12-2018

Outcome of the consultation with Member States, the applicant and EFSA on the pesticide risk assessment for mesotrione in light of confirmatory data

Outcome of the consultation with Member States, the applicant and EFSA on the pesticide risk assessment for mesotrione in light of confirmatory data

Published on: Wed, 19 Dec 2018 The European Food Safety Authority (EFSA) was asked by the European Commission to provide scientific assistance with respect to the risk assessment for an active substance in light of confirmatory data requested following approval in accordance with Article 6(1) of Directive 91/414/EEC and Article 6(f) of Regulation (EC) No 1107/2009. In this context EFSA's scientific views on the specific points raised during the commenting phase conducted with Member States, the applican...

Europe - EFSA - European Food Safety Authority EFSA Journal

27-9-2018

Review of the existing maximum residue levels for tembotrione according to Article 12 of Regulation (EC) No 396/2005

Review of the existing maximum residue levels for tembotrione according to Article 12 of Regulation (EC) No 396/2005

Published on: Wed, 26 Sep 2018 00:00:00 +0200 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance tembotrione. To assess the occurrence of tembotrione residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EU) No 188/2011 as well as the import tolerances and European author...

Europe - EFSA - European Food Safety Authority Publications

23-8-2018

The Manhattan Toy Company recalls Pull-Back Speedy Jets

The Manhattan Toy Company recalls Pull-Back Speedy Jets

The rubber tires can separate from the wheels posing a small parts choking hazard for small children.

Health Canada

20-6-2018

Bumbleride Inc recalls Bumbleride Speed 3-wheel jogging stroller

Bumbleride Inc recalls Bumbleride Speed 3-wheel jogging stroller

Health Canada's sampling and evaluation program has determined that this jogging stroller does not meet the sharp edge requirements of the Carriages and Strollers Regulations in Canada. The metal edge of the back hinge located on the right side of the jogging stroller can be sharp, posing a potential risk of cut or laceration.

Health Canada

2-10-2018

Ritemvia (Celltrion Healthcare Hungary Kft.)

Ritemvia (Celltrion Healthcare Hungary Kft.)

Ritemvia (Active substance: rituximab) - Centralised - Yearly update - Commission Decision (2018)6480 of Tue, 02 Oct 2018

Europe -DG Health and Food Safety

24-9-2018

Blitzima (Celltrion Healthcare Hungary Kft.)

Blitzima (Celltrion Healthcare Hungary Kft.)

Blitzima (Active substance: rituximab) - Centralised - Yearly update - Commission Decision (2018)6228 of Mon, 24 Sep 2018

Europe -DG Health and Food Safety

6-9-2018

 Trisenox (arsenic trioxide) supply shortage

Trisenox (arsenic trioxide) supply shortage

Europe - EMA - European Medicines Agency

23-7-2018

Rituzena (Celltrion Healthcare Hungary Kft.)

Rituzena (Celltrion Healthcare Hungary Kft.)

Rituzena (Active substance: rituximab) - Centralised - Yearly update - Commission Decision (2018)4884 of Mon, 23 Jul 2018

Europe -DG Health and Food Safety

22-7-2018

We'll consider regulatory options to speed up requiring companies to mitigate safety problems identified postmarket. Currently, mitigations such as new user training or new labeling can require rulemaking, which takes time and resources

We'll consider regulatory options to speed up requiring companies to mitigate safety problems identified postmarket. Currently, mitigations such as new user training or new labeling can require rulemaking, which takes time and resources

We'll consider regulatory options to speed up requiring companies to mitigate safety problems identified postmarket. Currently, mitigations such as new user training or new labeling can require rulemaking, which takes time and resources

FDA - U.S. Food and Drug Administration

3-5-2018

Remsima (Celltrion Healthcare Hungary Kft.)

Remsima (Celltrion Healthcare Hungary Kft.)

Remsima (Active substance: Infliximab) - Centralised - Yearly update - Commission Decision (2018)2769 of Thu, 03 May 2018

Europe -DG Health and Food Safety

3-5-2018

Trisenox (Teva B.V.)

Trisenox (Teva B.V.)

Trisenox (Active substance: Arsenic trioxide) - Centralised - Yearly update - Commission Decision (2018)2778 of Thu, 03 May 2018

Europe -DG Health and Food Safety

2-5-2018

Truxima (Celltrion Healthcare Hungary Kft.)

Truxima (Celltrion Healthcare Hungary Kft.)

Truxima (Active substance: rituximab) - Centralised - Yearly update - Commission Decision (2018)2707 of Wed, 02 May 2018

Europe -DG Health and Food Safety